Antipodes Partners’s EQT Corp EQT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-593,102
Closed -$32.3M 135
2025
Q3
$32.3M Sell
593,102
-359,038
-38% -$19M 0.72% 42
2025
Q2
$55.5M Sell
952,140
-467,814
-33% -$25.2M 1.72% 22
2025
Q1
$75.9M Sell
1,419,954
-54,157
-4% -$2.77M 2.38% 19
2024
Q4
$68M Buy
+1,474,111
New +$60.8M 2.36% 18
2023
Q3
Sell
-35
Closed -$1K 72
2023
Q2
$1K Sell
35
-522
-94% -$18.5K ﹤0.01% 69
2023
Q1
$17K Sell
557
-993
-64% -$31.9K ﹤0.01% 68
2022
Q4
$52K Sell
1,550
-2,560,099
-100% -$103M ﹤0.01% 55
2022
Q3
$104M Sell
2,561,649
-427,640
-14% -$18.5M 4.19% 6
2022
Q2
$103M Sell
2,989,289
-2,621,579
-47% -$108M 4.28% 6
2022
Q1
$193M Buy
5,610,868
+3,124,354
+126% +$76.2M 6.85% 1
2021
Q4
$54.2M Sell
2,486,514
-499,614
-17% -$10.5M 1.95% 21
2021
Q3
$61.1M Buy
+2,986,128
New +$57.8M 2.09% 21

Other funds holding EQT

Antipodes Partners's EQT Position: Q4 2025 in Review

Antipodes Partners sold out of EQT Corp (EQT) in Q4 2025, closing a stake of 593,102 shares — an estimated $32.3M sold.

Antipodes Partners first reported a position in EQT in Q3 2021 and held it in 12 quarters. The position peaked at $193M in Q1 2022. 1,107 funds tracked by Wall St. Rank hold EQT as of Q4 2025.

  • Antipodes Partners reported no remaining EQT Corp position as of Q4 2025 after selling out during the quarter.
  • Antipodes Partners sold 593,102 EQT Corp shares in Q4 2025, an estimated $32.3M.
  • Antipodes Partners first reported a position in EQT Corp in Q3 2021 and held it in 12 quarters.
  • Antipodes Partners's EQT Corp position peaked at $193M in Q1 2022.
  • 1,107 funds tracked by Wall St. Rank held EQT Corp as of Q4 2025.

Based on Antipodes Partners's 13F filing for Q4 2025, filed 5 Feb 2026.